Venture-Backed Startups

0 investors

Delos is an all-in-one AI platform that orchestrates existing language models and adds its own tools to handle everyday professional tasks such as writing emails, creating documents and presentations, preparing meetings and generating minutes, translation, sector research and collaborative document storage. It emphasizes data sovereignty, hosting all data on French servers (Scaleway, Paris) with no model training on user data, and lets users build custom AI agents.

1 investor

Delos is a managing general agent (MGA) that uses wildfire science and AI-based risk models to underwrite and offer homeowners insurance policies in areas of high wildfire risk, and provides homeowners with personalized home-hardening advice. It serves homeowners, with a stated focus on California, who struggle to find coverage due to nonrenewals.

6 investors

0 investors

0 investors

Delos Aqua farms and supplies king prawns sourced from Indonesia, positioning them as responsibly farmed seafood.

2 investors

Delox develops proprietary bio-decontamination solutions using solid-formulated hydrogen peroxide technology for healthcare, pharmaceutical, laboratory, and industrial environments where contamination control is critical. The company operates across Europe and North America, serving organizations in highly controlled settings that require precision decontamination with zero tolerance for failure.

1 investor

Delpharm is a contract development and manufacturing organization (CDMO) that develops and manufactures pharmaceutical products for the pharmaceutical industry across solid, sterile, semi-solid, and liquid dosage forms. With manufacturing sites across Europe and North America, the company ranks among the top 5 global CDMOs and specializes in pre-filled syringes, nasal sprays, and liquid pharmaceuticals.

1 investor

Delphi is an AI-powered assistant platform that helps venture capitalists scale their investment operations by automating deal screening, founder communication, and thought leadership distribution. The platform trains on a VC's own content and investment thesis to provide personalized feedback to founders and manage deal flow 24/7.

3 investors

Delphi Diagnostics develops genomic diagnostic tests for breast cancer that measure endocrine transcriptional activity to help healthcare providers personalize treatment decisions. Its tests target Stage II-III, HR+, HER2- breast cancer patients to identify who will benefit from dose-intense chemotherapy and to inform recurrence risk and prognosis.

2 investors

0 investors

Delphia is an investment firm that applies AI and data-driven quantitative models to financial markets, running strategies such as a market-neutral quant equity fund and its Oracle Alpha hedge fund. It builds products for professional investors and also offers tools like Tilt for individuals to invest in trends, and has open-sourced a portfolio backtesting framework.

4 investors

Delphia Therapeutics is a biotechnology company developing cancer medicines based on its activation lethality platform, aiming to create therapies effective on their own while combating resistance to targeted therapies. It focuses on oncology drug discovery and clinical development.

3 investors

Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.

1 investor

Delphi Behavioral Health Group operates a network of drug and alcohol detox and treatment centers offering personalized addiction treatment in intimate settings. The company serves individuals struggling with substance abuse, providing clinical care with low clinician-to-client ratios and aftercare services focused on relapse prevention.

1 investor

Website that reviews and compares online casinos operating without a Dutch (KSA/Cruks) license, focused on the Dutch-language market. It rates casinos holding other European licenses (e.g. Malta, UK) on bonuses, payment methods, game selection, and safety.

1 investor

Delphi Interactive is a game development and publishing company focused on AAA titles, working with iconic IP and creative studios. It is behind 007 First Light in partnership with IO Interactive and is leading the return of the FIFA simulation game.

1 investor

Delphina builds AI data agents, end-to-end analytics workflows, and shareable data apps that teams can generate from prompts and refine in chat. Its products produce context-aware dashboards, KPIs, charts, and forecasts backed by validated data.

1 investor

Delphinium is a boutique clinical research organization (CRO) based in Groningen, Netherlands, that conducts early-phase clinical trials with a focus on healthy volunteers across therapeutic areas including cardiology, neurology, and metabolic diseases. The company operates its own clinical research unit with 12 beds and in-house pharmacy, offering services in pharmacokinetics/pharmacodynamics, first-in-human, and bioequivalence studies.

1 investor

0 investors

Delphinus Lab builds ZKWASM, a zero-knowledge proof system that compiles WebAssembly application logic into provable computations, and operates zkwasmhub for hosting ZKWASM decentralized applications. It targets developers building provable dapps and games on blockchain infrastructure.

3 investors

Delphisonic offers DS-Insight, software that turns real-time sensor data into dashboards, alerts, and AI-driven predictive analytics for monitoring asset health and enabling predictive maintenance. It serves industrial operators, engineers, and managers, integrating with ERP, MES, SCADA, and DS-X Cloud platforms.

1 investor

Perforce Delphix is a data automation platform that delivers, masks, and generates synthetic test data for enterprise DevOps, testing, analytics, and AI workflows. It serves large enterprises across financial services, healthcare, insurance, and technology sectors to accelerate development cycles, ensure data compliance with regulations like GDPR and HIPAA, and reduce infrastructure costs.

7 investors

Delpho is a balance-sheet layer for Hyperliquid that enables users to mint USDV, a collateral-backed stablecoin, against digital assets at 0% APR without liquidating holdings. The protocol offers yield through staked USDV (sUSDV), funded by delta-neutral positions and funding rates on Hyperliquid.

1 investor